These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 30254436)

  • 1. A novel microfluidic liposomal formulation for the delivery of the SN-38 camptothecin: characterization and in vitro assessment of its cytotoxic effect on two tumor cell lines.
    Casadó A; Sagristá ML; Mora M
    Int J Nanomedicine; 2018; 13():5301-5320. PubMed ID: 30254436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and characterization of a novel liposome-based formulation of SN-38.
    Zhang JA; Xuan T; Parmar M; Ma L; Ugwu S; Ali S; Ahmad I
    Int J Pharm; 2004 Feb; 270(1-2):93-107. PubMed ID: 14726126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation and in vitro characterization of thermosensitive liposomes for the delivery of irinotecan.
    Casadó A; Sagristá ML; Mora M
    J Pharm Sci; 2014 Oct; 103(10):3127-38. PubMed ID: 25091422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved selectivity and cytotoxic effects of irinotecan via liposomal delivery: A comparative study on Hs68 and HeLa cells.
    Casadó A; Mora M; Sagristá ML; Rello-Varona S; Acedo P; Stockert JC; Cañete M; Villanueva A
    Eur J Pharm Sci; 2017 Nov; 109():65-77. PubMed ID: 28735042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative determination of liposomal irinotecan and SN-38 concentrations in plasma samples from children with solid tumors: Use of a cryoprotectant solution to enhance liposome stability.
    Nair S; Selvo NS; Stolarski A; Klee B; Federico SM; Stewart CF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Sep; 1245():124273. PubMed ID: 39146822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel camptothecin analogue (gimatecan)-containing liposomes prepared by the ethanol injection method.
    Stano P; Bufali S; Pisano C; Bucci F; Barbarino M; Santaniello M; Carminati P; Luisi PL
    J Liposome Res; 2004; 14(1-2):87-109. PubMed ID: 15461935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposomal irinotecan: formulation development and therapeutic assessment in murine xenograft models of colorectal cancer.
    Messerer CL; Ramsay EC; Waterhouse D; Ng R; Simms EM; Harasym N; Tardi P; Mayer LD; Bally MB
    Clin Cancer Res; 2004 Oct; 10(19):6638-49. PubMed ID: 15475454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. pH-dependent association of SN-38 with lipid bilayers of a novel liposomal formulation.
    Peikov V; Ugwu S; Parmar M; Zhang A; Ahmad I
    Int J Pharm; 2005 Aug; 299(1-2):92-9. PubMed ID: 15996839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PEG-coated irinotecan cationic liposomes improve the therapeutic efficacy of breast cancer in animals.
    Zhang L; Cao DY; Wang J; Xiang B; Dun JN; Fang Y; Xue GQ
    Eur Rev Med Pharmacol Sci; 2013 Dec; 17(24):3347-61. PubMed ID: 24379067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended topoisomerase 1 inhibition through liposomal irinotecan results in improved efficacy over topotecan and irinotecan in models of small-cell lung cancer.
    Leonard SC; Lee H; Gaddy DF; Klinz SG; Paz N; Kalra AV; Drummond DC; Chan DC; Bunn PA; Fitzgerald JB; Hendriks BS
    Anticancer Drugs; 2017 Nov; 28(10):1086-1096. PubMed ID: 28857767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of quercetin combined with anticancer drugs on metastasis-associated factors of gastric cancer cells: in vitro and in vivo studies.
    Lei CS; Hou YC; Pai MH; Lin MT; Yeh SL
    J Nutr Biochem; 2018 Jan; 51():105-113. PubMed ID: 29125991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and characterization of lyophilised egg PC liposomes incorporating curcumin and evaluation of its activity against colorectal cancer cell lines.
    Pandelidou M; Dimas K; Georgopoulos A; Hatziantoniou S; Demetzos C
    J Nanosci Nanotechnol; 2011 Feb; 11(2):1259-66. PubMed ID: 21456169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irinophore C™, a lipid nanoparticulate formulation of irinotecan, improves vascular function, increases the delivery of sequentially administered 5-FU in HT-29 tumors, and controls tumor growth in patient derived xenografts of colon cancer.
    Neijzen R; Wong MQ; Gill N; Wang H; Karim T; Anantha M; Strutt D; Waterhouse D; Bally MB; Tai IT; Ng SS; Yapp DT
    J Control Release; 2015 Feb; 199():72-83. PubMed ID: 25497312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PEGylated Liposomes of Meloxicam: Optimization by Quality by Design, in vitro Characterization and Cytotoxicity Evaluation.
    Shaji J; Menon I
    Pharm Nanotechnol; 2017; 5(2):119-137. PubMed ID: 28462699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biologically active camptothecin derivatives for incorporation into liposome bilayers and lipid emulsions.
    Lundberg BB
    Anticancer Drug Des; 1998 Jul; 13(5):453-61. PubMed ID: 9702210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the cytotoxic effect of camptothecin solid lipid nanoparticles on MCF7 cells.
    Acevedo-Morantes CY; Acevedo-Morantes MT; Suleiman-Rosado D; Ramírez-Vick JE
    Drug Deliv; 2013 Nov; 20(8):338-48. PubMed ID: 24024505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folate receptor-mediated celastrol and irinotecan combination delivery using liposomes for effective chemotherapy.
    Soe ZC; Thapa RK; Ou W; Gautam M; Nguyen HT; Jin SG; Ku SK; Oh KT; Choi HG; Yong CS; Kim JO
    Colloids Surf B Biointerfaces; 2018 Oct; 170():718-728. PubMed ID: 30005409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel sulfobutyl ether cyclodextrin gradient leads to highly active liposomal irinotecan formulation.
    Li C; Cui J; Wang C; Li Y; Zhang L; Xiu X; Li Y; Wei N; Zhang L; Wang P
    J Pharm Pharmacol; 2011 Jun; 63(6):765-73. PubMed ID: 21585373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective irinotecan (CPT-11)-containing liposomes: intraliposomal conversion to the active metabolite SN-38.
    Sadzuka Y; Hirotsu S; Hirota S
    Jpn J Cancer Res; 1999 Feb; 90(2):226-32. PubMed ID: 10189894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of human colon cancer xenografts with TRA-8 anti-death receptor 5 antibody alone or in combination with CPT-11.
    Oliver PG; LoBuglio AF; Zinn KR; Kim H; Nan L; Zhou T; Wang W; Buchsbaum DJ
    Clin Cancer Res; 2008 Apr; 14(7):2180-9. PubMed ID: 18381960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.